News

conference

Nov 7, 2022

2022 - SITC - SQ2270 Poster

SQ2270, a Novel MMAE-based Click Chemistry Therapeutic, Promotes Tumor Growth Inhibition and Extensive Immune Cell Infiltration in the RENCA Cancer Model

conference

Nov 7, 2022

2022 - SITC - SQ3370 Poster

Treatment with SQ3370, a doxorubicin-based click chemistry therapeutic, promotes immune activation in the tumor microenvironment

media

Nov 2, 2022

Drug Discovery & Development

Click chemistry company Shasqi has a link to the Nobel Prize in Chemistry

media

Oct 27, 2022

PharmaVoice

The first company to use Nobel-winning click chemistry in humans is on a mission to transform oncology

conference

Oct 17, 2022

2022 - AACR - Tumor IO

Combining SQ3370, a Doxorubicin-based Therapeutic, with TLR and STING Agonists Enhances Antitumor Effect in Murine Tumor Models

press

Oct 6, 2022

Press Release

Shasqi Scientific Advisor Carolyn Bertozzi Awarded Nobel Prize for the Development of Click Chemistry

media

Oct 5, 2022

Washington Post

Nobel Prize awarded to three scientists for work in click chemistry, which links molecules quickly

media

Oct 5, 2022

C&EN

Click and bioorthogonal chemistry win 2022 Nobel Prize in Chemistry

media

Sep 26, 2022

Endpoints News

Pioneering Click Chemistry In Humans

press

Sep 12, 2022

Press Release

Shasqi Advances SQ3370 to Phase 2 in Solid Tumors

conference

Aug 31, 2022

2022 - World ADC

Click Activated Protodrugs Against Cancer (CAPAC):A modular platform for tumor-directed oncology therapeutics

conference

Aug 31, 2022

2022 - ESMO

Phase 1 Clinical & Immunologic Data of SQ3370 in Advanced Solid Tumors